A Study to Explore the Pharmacokinetics of Rilpivirine With Rifabutin in Healthy Participants

NCT01615614 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Rilpivirine
DRUG: Rifabutin

Sponsor

Janssen R&D Ireland